Gynecologic Cancer

Top Story

Breast surgery alone may be safer than in combination with plastic, gynecologic surgeries

Breast surgery alone may be safer than in combination with plastic, gynecologic surgeries
October 14, 2019
In the Journals

Nivolumab-bevacizumab combination safe, active in relapsed ovarian cancer

October 11, 2019
A combination of nivolumab and bevacizumab appeared safe and induced responses among women with relapsed ovarian cancer, according to results of a single-arm, phase 2…
In the Journals

Power morcellation technique increases mortality risk for women with occult uterine sarcoma

October 11, 2019
Uncontained power morcellation appeared associated with increased risk for mortality among women with occult uterine sarcoma, according to study results published in…
FDA News

FDA grants fast track designation to navicixizumab for pretreated ovarian cancer

October 9, 2019
The FDA granted fast track designation to navicixizumab for the treatment of women with heavily pretreated high-grade ovarian, primary peritoneal or fallopian tube…
More Headlines »
CME

Using the Latest Clinical Advances to Guide Your Practice: A Multidisciplinary Tumor Board

This activity is supported by an educational grant from Merck & Co., Inc.

The treatment paradigm for the management of patients with advanced cancer has changed dramatically within recent years…
More »
Video
Meeting News

VIDEO: Merck executive highlights ASCO data in lung cancer, Merkel cell carcinoma

June 18, 2018
More »